Yousuf Zafar, MD MHS

5K posts

Yousuf Zafar, MD MHS

@yzafar

Oncologist. CMO @myAccessHope. Adjunct Professor @DukeMedSchool. Photographer.

Durham, NC Katılım Aralık 2007

612 Takip Edilen6.2K Takipçiler

Yousuf Zafar, MD MHS@yzafar·13 Kas

I’m thrilled to join AccessHope as chief medical officer! At AccessHope, our mission is clear: optimize patient outcomes & make cancer care more accessible and equitable for all. I’m deeply honored to join this incredible team, which keeps patients at the heart of every decision

AccessHope@myaccesshope

We’re thrilled to announce that renowned oncologist @yzafar, M.D., MHS has joined as our new chief medical officer and digital health veteran @peterbridges has joined as our chief strategy and growth officer. Debra Morris, our COO/CFO has also been promoted to president. myaccesshope.org/press-releases…

English

5.4K

Yousuf Zafar, MD MHS retweetledi

Jeffrey peppercorn MD@EthicsdoctorP·15 Haz

Proud of this work and it’s legacy in highlighting the need to identify and address financial burdens faced by patients with cancer - and my enduring friendship with the fantastic @yzafar Reflections on the Financial Toxicity of Cancer: 10 Years Later academic.oup.com/oncolo/article…

English

5.8K

Yousuf Zafar, MD MHS@yzafar·12 Oca

So much fun chatting with @pbcancerdoc about how @ThymeCares is addressing key challenges in cancer care delivery

English

917

Yousuf Zafar, MD MHS@yzafar·10 Oca

@marklewismd I don't twitter much these days, but when I do, it's to show love for genius like this.

English

765

Mark Lewis, MD, FASCO@marklewismd·10 Oca

“I’ll take Rejected Red Hot Chili Peppers album titles for $1000, please” #MedTwitter

INDS-115@pod_tina

Zones of the adrenal gland: Salt Sugar Sex Panic

English

9.5K

Yousuf Zafar, MD MHS retweetledi

ASCO@ASCO·14 Eki

For #ASCODailyNews, @yzafar breaks down how technology & data can lower #cancercare costs, reduce acute care utilization, & streamline clinician workflow, allowing the real work of precision care delivery to begin: fal.cn/3sJHs #healthtech #precisionmedicine

English

Yousuf Zafar, MD MHS@yzafar·4 Eki

LOVE this: "Looking for an actually concise explanation of a half-century’s worth of research and arguments about health care spending in the U.S.?" Well, here it is in one ppt. Thanks, @bobjherman @statnews statnews.com/2022/10/03/get… cc: @DusetzinaS @StephWheelerUNC

English

Yousuf Zafar, MD MHS@yzafar·2 Eki

@QasimHussainiMD @fumikochino @ASCO @TheIHI As I mentioned earlier with @GreenupRachel, I didn’t really mentor you guys. I was just along for the ride! Brilliant mentees always make the mentor look good 🙂

English

Qasim Hussaini, MD@QasimHussainiMD·2 Eki

@fumikochino @ASCO @yzafar @TheIHI Ditto for me! Dr @yzafar is a national treasure.

English

Fumiko Ladd Chino, MD, FASCO@fumikochino·2 Eki

An @asco #ASCOQLTY22 mentor appreciation post: In 2011, I met Dr @yzafar at an @TheIHI local chapter talk about #financialToxicity. If I had not met him (and had the mentorship & sponsorship he so generously provided) I am confident I would not be anywhere near where I am today.

Fumiko Ladd Chino, MD, FASCO tweet media

English

Yousuf Zafar, MD MHS@yzafar·30 Eyl

@EthicsdoctorP @ZekeEmanuel I love this idea -- but if you suggest this to a payer (as I did once), they'll say, "Yeah, but then what happens when the cardiologists and rheumatologists come to us with similar suggestions?" 🤷‍♂️🤦‍♂️ #ASCOQLTY22

English

Jeffrey peppercorn MD@EthicsdoctorP·30 Eyl

A bold but remarkably common sense proposal to eliminate financial toxicity in cancer care from Dr. Zeke Emmanuel ➡️ after cancer dx = no out of pocket costs. 👏👏👏 #ASCOQUALITY22 #financialtoxicity ⁦@ZekeEmanuel⁩ ⁦@yzafar⁩

English

Yousuf Zafar, MD MHS retweetledi

Fumiko Ladd Chino, MD, FASCO@fumikochino·6 Tem

Scientists NEED to become better communicators. Proud of this manuscript highlighting HOW to present your research to diverse audiences, WHY it matters, and some Do's & Don'ts. With: Drs @aaronecarroll @DusetzinaS @yzafar & Ms. @sangerkatz in @JNCI_Now academic.oup.com/jncimono/artic…

English

137

Yousuf Zafar, MD MHS@yzafar·7 Haz

Deciding between adjuvant therapy yes/no for stage II #coloncancer? Check out @gabe_a_brooks great summary. I would only add this: patient preference plays a role, of course #ASCO22

Gabriel Brooks@gabe_a_brooks

My preliminary takeaways re: DYNAMIC: In stage 2 colon cancer, only three biomarkers are ultimately useful for selecting adjuvant therapy candidates after R0 resection. They are: T4 dMMR ctDNA positivity (provisional) 1/4 #ASCO22

English

Yousuf Zafar, MD MHS@yzafar·7 Haz

@manjuggm @pashtoonkasi @marklewismd @ASCO @TheLancet @OncoAlert @BenWestphalen @GillSharlene @JenSeligmann @aparna1024 @skopetz @profevasegelov @BrandonMeyersMD @ChiaraCrem1 Not imagining!

English

Manju George MVSc PhD@manjuggm·7 Haz

@yzafar @pashtoonkasi @marklewismd @ASCO @TheLancet @OncoAlert @BenWestphalen @GillSharlene @JenSeligmann @aparna1024 @skopetz @profevasegelov @BrandonMeyersMD @ChiaraCrem1 Didn't women #CRC patients doing better in different contexts show up at different talks at #ASCO22? Or am I imagining it?

English

Mark Lewis, MD, FASCO@marklewismd·7 Haz

My top 5 GI abstracts of #ASCO22 (while bending the knee to my breast oncology colleagues)

English

272

Yousuf Zafar, MD MHS@yzafar·7 Haz

@pashtoonkasi @marklewismd @ASCO @TheLancet @OncoAlert @manjuggm @BenWestphalen @GillSharlene @JenSeligmann @aparna1024 @skopetz @profevasegelov @BrandonMeyersMD @ChiaraCrem1 Helpful figure - but despite the higher odds of right-sided in women, can someone then explain all the unplanned subgroup analyses showing women do better?

English

Pashtoon Kasi MD, MS@pashtoonkasi·7 Haz

@marklewismd 🤔Instead of PARADIGM alone as a study, I’d say that this @ASCO #ASCO22 is a paradigm shift for the subset of pts with #colorectalcancer who are candidates for EGFR⛔️1st-line: ✔️LEFT ❌RAS ❌RAF ❌HER2 🔌 for our📝@TheLancet & my ✍🏽 #SciArt. @OncoAlert thelancet.com/journals/lance…

Chicago, IL 🇺🇸 English

Yousuf Zafar, MD MHS@yzafar·7 Haz

@marklewismd @offhandmanor1 Totes.

Català

Mark Lewis, MD, FASCO@marklewismd·7 Haz

@offhandmanor1 I think the real question is: was this near-miraculous, headline-worthy outcome specific to dostarlimab or is this a class effect?

English

Yousuf Zafar, MD MHS@yzafar·7 Haz

@CAJonesMD @fumikochino I miss your face, @CAJonesMD

English

Chris Jones, MD, MBA, CPC@CAJonesMD·7 Haz

@fumikochino @yzafar You could not have conjured a better pair!!!!

English

Fumiko Ladd Chino, MD, FASCO@fumikochino·7 Haz

Amazing to catch up (even briefly) with the dynamic duo of Drs @yzafar and Fatima Rangwala. Dr Rangwala was my clinical mentor for 3rd year and Dr Zafar is literally the reason why I can do anything I do now. So much respect due to these phenomenal mentors and sponsors. 🙏

English

Yousuf Zafar, MD MHS@yzafar·7 Haz

@fumikochino I loved catching up and seeing all the amazing work you’re doing, doctor! Keep fighting the good fight 😉

English

Yousuf Zafar, MD MHS retweetledi

Erika Hamilton, MD, FASCO@ErikaHamilton9·6 Haz

40% of Black patients say no one mentioned clinical trials to them. >90% say they want information on trials. This is shameful. We, as a community, need to do SO MUCH BETTER. @tigerlilycares #bcsm #clinicaltrials #ASCO22 @OncoAlert

Chicago, IL 🇺🇸 English

236

Yousuf Zafar, MD MHS retweetledi

Mark Lewis, MD, FASCO@marklewismd·6 Haz

@pashtoonkasi @ASCO @OncoAlert @ryanhuey @gabe_a_brooks @Jcj84Jeremy @mdmanishshah @BenWestphalen @AndreaCercek @anup_kasi @manjuggm @mtmdphd In her PARADIGM plenary discussion @ChiaraCrem1 (who is OWNING #ASCO22 podiums by the way) observed a ~3.5 month *loss* of median OS with bev first in 1st line L-sided ras/braf wt, MSS colon cancer

English

Yousuf Zafar, MD MHS@yzafar·6 Haz

@haleyarden1 @nounproject Love that site

English

Yousuf Zafar, MD MHS@yzafar·6 Haz

You know it’s big news when my mom in Ohio called me about this study. Congratulations to @AndreaCercek and team for a huge result for the benefit of our patients #ASCO22

Andrea Cercek@AndreaCercek

Very proud of our study published in @NEJM. 100% clinical complete response with dostarlimab alone in mismatch repair-deficient locally advanced #RectalCancer. No radiation or surgery! @ASCO #ASCO22 @MSKCancerCenter nejm.org/doi/full/10.10…

English

Yousuf Zafar, MD MHS@yzafar·6 Haz

@fumikochino @ASCO @JCO_ASCO @JCOOP_ASCO @JCOCCI_ASCO @JCOGO_ASCO @JCOPO_ASCO

GIF

QME

Fumiko Ladd Chino, MD, FASCO@fumikochino·6 Haz

#ASCO22 SWAG alert: the @ASCO journals publications lounge has some SERIOUSLY adorable post-it note “books” and I’m geeking out over here like Any Santiago from Brooklyn 99. 😅😂🤣 @JCO_ASCO @JCOOP_ASCO @JCOCCI_ASCO @JCOGO_ASCO @JCOPO_ASCO 📚

English

Keşfet

@pbcancerdoc @ThymeCares @marklewismd @bobjherman @statnews @DusetzinaS @QasimHussainiMD @fumikochino